With a rich history spanning over 75 years, Lannett CDMO has established itself as a trusted partner in the pharmaceutical industry. Our dedicated manufacturing site in Seymour, Indiana, spans 30 acres and boasts a track record of delivering high-quality oral solid doses and liquid finished products to clients worldwide.

Our team of experienced professionals has successfully brought over 100 unique pharmaceutical products to market. With a strong focus on quality, on-time delivery, and schedule attainment, we’re committed to helping you accelerate your time to market.

Type of Drugs Manufactured:

Small Molecule

CDMO Services:

Packaging, Regulatory Services, Analytical Development, Fill/Finish, Tech Transfer

Number of Manufacturing Facilities:

1

High Potent Products Capabilities:

OEB 3; OEB 4-5

Controlled Substances:

Schedule I-V

Facilities Locations:

North America

Regulatory Approvals for Facilities:

FDA (United States); EMA (Europe); ISO; GMP; PMDA (Japan); Health Canada; DEA

Manufacturing Technologies:

Liquids; Semi-solids; Solids

Current Capacity:

2.5 Billion OSD units and 1.0 Billion Liters of Liquids

Lannett CDMO is committed to providing top-quality contract development and manufacturing services to the pharmaceutical industry. For more information, please visit lannettcdmo.com